A carregar...

Population-based estimates of survival and cost for metastatic melanoma

BACKGROUND: Fewer than half of all patients with metastatic melanoma survive more than 1 year. Standard treatments have had little success, but recent therapeutic advances offer the potential for an improved prognosis. In the present study, we used population-based administrative data to establish r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: McCarron, C.E., Ernst, S., Cao, J.Q., Zaric, G.S.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4608398/
https://ncbi.nlm.nih.gov/pubmed/26628865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.22.2557
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!